Log has written
WEDNESDAY, NOVEMBER 25, 2009
mint Mobile
|
e-paper
|
TODAY'S NEWSPAPER
|
mint CODE
Home
1
MarketInfo
106
Money Matters
2
Equities
Mutual Funds
Commodities
IPOs
Personal Finance
Global Markets
Derivatives
Bonds
Currency
Real Estate
Venture Capital
Economy & Politics
11
Policy Tracker
Political Economy
Agriculture
Human Development
Indicators
Infrastructure
Corporate News
3
Financial Results
World Business
Mergers Acquisitions
Sector Spotlight
Views
4
Our View
Their View / Interview
Your View
Other views
The Indian Century
Quick Edit
Columns
88
Views
News
Features
Business of Life
5
Weekend Planner
Gadgets
Homes
Personal Finance
Health
Technology
6
Tech Life
Tech News
Marketing & Media
7
Entertainment
Advertising
Campaign
Business Of Sports
International News
8
Asia
Europe
North America
Rest Of World
Lounge
9
Careers
109
Budget 2009
126
Environment
125
ADVERTISEMENT
Elections 2009
124
Book Reviews
118
Profiles
10
Ideators
Business People
Social Activists
Bureaucrats
Enterprise
117
Blogs
111
Photo Gallery
81
Videos
107
Radio
119
Special Report
98
Mint Reports
101
Banking
Technology
Webcast Archive
104
Partners
Wall Street Journal
Tools
Mint Mobile
RSS Feeds
RSS Story
Desktop Alert
mint e-paper
Email Alerts
Daily Newsletter
Follow us on Twitter
Follow us on Facebook
ADVERTISEMENT
Sites
Hindustan Times
Hindustan
HT Next
Fever 104
Shine: Jobs in India
DesiMartini Friends
ADVERTISEMENT
Outlicensing
Glenmark buckles as Eli Lilly halts drug trials
C.H. Unnikrishnan and Radhieka Pandeya 10:29 PM | October 24,2008
Glenmark shares fall 20%; suspension may put a question mark on licensing deal with Eli Lilly for pain molecule
FIND MORE ARTICLES ON:
Company News
Glenmark Pharmaceuticals Ltd
US
Outlicensing